Macau approves IASO Bio’s multiple myeloma therapy
The application is supported by data from the multi-site Phase I/II FUMANBA-1 trial.
Approvals
Genmab’s Tivdak approved in Japan for advanced cervical cancer
EC approves MSD’s pneumococcal 21-valent conjugate Capvaxive
FDA approves GSK’s Blujepa for uncomplicated UTIs
FDA approves IND application for Everest’s cancer vaccine
China conditionally approves Hutchmed’s Tazverik for follicular lymphoma
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxia
